news
Big pharma establishes new industry standards group
Pharma companies involved include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis, and Pfizer.
List view / Grid view
Allergan
news
NIBSC – MHRA, go under the Microscope in the Run-up to their Opening Keynote at Allergies 2016
19 May 2016 | By SMI
SMi are thrilled to have Dr Carl Dolman from the National Institute for Biologics, Standard and Control (NIBSC), a centre of the MHRA, present an opening keynote at the 3rd annual Allergies conference when it returns to London on 6th & 7th July...
news
Allergan signs $3.35 billion Alzheimer’s treatment deal with Heptares
7 April 2016 | By Victoria White, Digital Content Producer
Allergan is to license exclusive global rights to a broad portfolio of novel subtype-selective muscarinic receptor agonists in development by Heptares...
news
Allergan and Pfizer terminate merger agreement
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury to reform inversion tax rules, which the companies concluded qualified as an “Adverse Tax Law Change”. Market rumour suggests that Pfizer will now target Shire or AstraZeneca and shares in both companies went up with the…
news
Rapastinel demonstrates pro-cognitive benefits in animal model of cognitive impairment
19 January 2016 | By Victoria White
Allergan has announced new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function...
news
Allergan and Rugen to develop ASD and OCD therapies
25 November 2015 | By Victoria White
Rugen has already demonstrated efficacy for its compounds in animal models of ASD and OCD...